All In Biotech

Drug Trial Radar · NCT07287670

EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

A Phase 2 Randomized, Double-blind, Placebo-Controlled Study to Assess the Safety and Efficacy of MTX-474 in the Treatment of Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

Last checked: Nov 19, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

85

Planned (sponsor's estimate)

Start

Apr 16, 2026

Primary completion

Dec 2028

Study completion Dec 2028

Sponsor

Lead sponsor
Mediar TherapeuticsIndustry
Sponsor type
Industry
First posted
Dec 17, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Phase 2 Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of MTX-474 in Participants with Diffuse Cutaneous Systemic Sclerosis (dcSSc)

Conditions

  • Diffuse Cutaneous Systemic Sclerosis

Interventions

  • MTX-474Biological

    Dosage level: 4 mg/kg Unit dose strength: 50mg/ml MTX-474 is a human immunoglobulin G1 (IgG1) monoclonal antibody that binds the human EphrinB2 with high specificity and high affinity. MTX-474 is being developed as a therapy for patients with systemic sclerosis (SSc).

  • PlaceboOther

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in Modified Rodnan Skin Score (mRSS)Time frame: Baseline to week 24

Locations

58 sites in 10 countries. Site status is shown where the registry gives one.

  • EncompaSSc site in Phoenix, AZ

    Phoenix, Arizona · Not yet recruiting

  • EncompaSSc site in La Jolla, CA

    La Jolla, California · Not yet recruiting

  • EncompaSSc site in Loma Linda, CA

    Loma Linda, California · Not yet recruiting

  • University of California Los Angeles Scleroderma Center

    Los Angeles, California · Recruiting

  • NewportNativeMD, Inc.

    Newport Beach, California · Recruiting

  • EncompaSSc site in Palo Alto, CA

    Palo Alto, California · Not yet recruiting

  • University of Colorado Center for Lungs/Breathing/Scleroderma Clinic

    Aurora, Colorado · Recruiting

  • Clinical Research of West Florida

    Clearwater, Florida · Recruiting

  • Sarasota Arthritis Center

    Sarasota, Florida · Recruiting

  • Clinical Research of West Florida

    Tampa, Florida · Recruiting

  • EncompaSSc site in Kansas City, KS

    Kansas City, Kansas · Not yet recruiting

  • Johns Hopkins University

    Baltimore, Maryland · Recruiting

  • Brigham and Women's Hospital

    Boston, Massachusetts · Recruiting

  • Boston Medical Center

    Boston, Massachusetts · Recruiting

  • EncompaSSc site in Minneapolis, MN

    Minneapolis, Minnesota · Not yet recruiting

  • NYU Langone Health

    Brooklyn, New York · Recruiting

  • EncompaSSc site in Cleveland, OH

    Cleveland, Ohio · Not yet recruiting

  • The University of Oklahoma Health Sciences Center

    Oklahoma City, Oklahoma · Recruiting

  • EncompaSSc site in Philadelphia, PA

    Philadelphia, Pennsylvania · Not yet recruiting

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania · Recruiting

  • Stryde Research - DFW

    Allen, Texas · Recruiting

  • Baylor Scott & White Research Institute

    Dallas, Texas · Recruiting

  • EncompaSSc site in Houston, TX

    Houston, Texas · Not yet recruiting

  • Griffith University (Clinical Trial Unit)

    Southport, Queensland, Australia · Recruiting

  • Veracity Clinical Research

    Woolloongabba, Queensland, Australia · Recruiting

  • Austin Health

    Heidelberg, Victoria, Australia · Recruiting

  • EncompaSSc site in La Tronche, France

    La Tronche, France · Not yet recruiting

  • EncompaSSc site in Montpellier, France

    Montpellier, France · Not yet recruiting

  • EncompaSSc site in Paris, France

    Paris, France · Not yet recruiting

  • EncompaSSc site in Strasbourg, France

    Strasbourg, France · Not yet recruiting

  • EncompaSSc site in Toulouse, France

    Toulouse, France · Not yet recruiting

  • EncompaSSc site in Vandœuvre-lès-Nancy, France

    Vandœuvre-lès-Nancy, France · Not yet recruiting

  • EncompaSSc site in Ancona, Italy

    Ancona, Italy · Not yet recruiting

  • EncompaSSc site in Catania, Italy

    Catania, Italy · Not yet recruiting

  • EncompaSSc site in Genoa, Italy

    Genoa, Italy · Not yet recruiting

  • EncompaSSc site in Milan, Italy

    Milan, Italy · Not yet recruiting

  • EncompaSSc site in Modena, Italy

    Modena, Italy · Not yet recruiting

  • EncompaSSc site in Roma, Italy

    Roma, Italy · Not yet recruiting

  • EncompaSSc site in Groningen, Netherlands

    Groningen, Netherlands · Not yet recruiting

  • Aotearoa Clinical Trials

    Auckland, New Zealand · Recruiting

Showing 40 of 58 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.